Projects

ICMR MINDS

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2023 - Ongoing

Project Lead

Dr. Johnson R Pradeep, Dr. Prem K Mony. Dr. Srinivasan K

Authors

Dr. Johnson R Pradeep, Dr. Prem K Mony. Dr. Srinivasan K, Dr. B Ramakrishna Goud, Dr. Luke Salazar, Dr. Farah Naaz Fathima, Dr. Soumya Umesh, Dr. Pooja R Sridhar

Project Status

ongoing

Project Type

ICMR study